North America is expected to dominate the global Braf Kinase Inhibitors market over the forecast period. This is attributed to the rising melanoma case numbers in the US and Canada along with high ado
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |